Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)

Stopped Due to unexpected operational issues outside of Lilly's control the study has been closed

Conditions

• Spondylitis, Ankylosing

Interventions

• DRUG: Ixekizumab
• DRUG: Placebo
• DRUG: Adalimumab

Sponsor

Eli Lilly and Company